ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2013

Cardiovascular Disease

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

37,307Medicare Part D Prescriptions Filled, Including Refills

Rank: 1 out of 1498

$3.43M Total Retail Price of All Prescriptions

Rank: 1 out of 1498

1,370 Patients Receiving at Least One Drug in Part D
94% Patients 65 Years and Older
74% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg 81928cdb0ebe162ff75cf405bfacadd396bf3ec84bc467b6f3e612dd63daa776 Average for
this specialty
in New York
Lower avg 72b1978e1dcc0b845f89d17d692cfff7aeaf8d8bce70310d8bfc535db2daf62a

Schedule Two
Controlled Substances

2% of this provider’s 1,370 patients filled at least one prescription for a schedule two drug, compared to an average of 0%.

Schedule Three
Controlled Substances

1% of this provider’s 1,370 patients filled at least one prescription for a schedule three drug, compared to an average of 0%.

Brand Name Drugs

35% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$92 was the average price of a prescription from this provider, compared to $75 among peers.

Prescriptions per Patient

27 is the average number of prescriptions (including refills) per patient, compared to an average of 11.


This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

B

A benzodiazepine, or tranquilizer. More » The American Geriatrics Society says these drugs increase the risk of cognitive impairment, delirium, falls and fractures in older adults.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled with Refills Prescriptions
to 65+
Patients Recieving this Drug Category For this Prescriber For All Prescribers in
This Specialty in New York
SIMVASTATIN 2,063 1,976 394 1 4
ATENOLOL 1,895 1,795 337 10 2 13
LOSARTAN POTASSIUM 1,679 1,581 343 3 11
AMLODIPINE BESYLATE 1,579 1,509 293 4 3
ATORVASTATIN CALCIUM 1,498 1,440 304 5 1
EVISTA 1,360 1,327 218 10 6 82
CLOPIDOGREL 1,063 1,027 197 7 5
METOPROLOL SUCCINATE 871 849 162 8 2
OMEPRAZOLE 765 753 184 9 21
METFORMIN HCL ER 710 671 154 10 69
DIOVAN 659 654* 113 11 18
JANUVIA 648 631 108 12 47
ALLOPURINOL 522 517* 115 13 48
ZOLPIDEM TARTRATE 510 505* 95 14 24
METOPROLOL TARTRATE 491 465 100 15 7
LEVOTHYROXINE SODIUM 488 483* 95 16 20
XARELTO 481 481 86 17 31
FUROSEMIDE 439 425 95 18 6
LOVAZA 438 413 73 19 40
AZITHROMYCIN 429 424* 294 20 65
PRAVASTATIN SODIUM 424 403 81 21 17
LIDODERM 422 417* 73 22 87
CLONIDINE HCL 394 389* 77 23 59
LOVASTATIN 393 381 74 24 67
TAMSULOSIN HCL 378 373* 100 25 38
RANITIDINE HCL 360 355* 63 26 73
LISINOPRIL 341 336* 73 27 9
GLIMEPIRIDE 337 319 71 28 70
POTASSIUM CHLORIDE 316 311* 57 29 33
AMMONIUM LACTATE 310 305* 80 30 143
DONEPEZIL HCL 308 308 55 31 72
BENICAR 291 291 59 32 53
WARFARIN SODIUM 288 267 59 33 10
METFORMIN HCL 284 260 61 34 23
NEXIUM 261 256* 58 35 35
FLUTICASONE PROPIONATE 254 249* 101 36 92
FENOFIBRATE* 254 223 51 36 74
LOSARTAN-HYDROCHLOROTHIAZIDE 234 219 51 38 27
CRESTOR 230 225* 45 39 12
DIGOXIN 216 211* 34 40 54
POLYETHYLENE GLYCOL 3350 210 205* 46 41 154
ALENDRONATE SODIUM 207 193 58 42 55
GLYBURIDE-METFORMIN HCL 182 168 33 R 43 149
AZOR 178 178 38 44 100
PATADAY 175 170* 45 45 249
PRADAXA 174 174 23 46 26
DIGOX 165 165 33 47 19
HYDROCORTISONE VALERATE 162 157* 84 48 213
FINASTERIDE 158 158 41 49 91
SYNTHROID 157 146 32 50 42
FELODIPINE ER 155 155 24 51 105
TRIAMTERENE-HCTZ 154 143 37 52 49
ADVAIR DISKUS 153 148* 49 53 80
FAMOTIDINE* 153 148* 36 53 67
GABAPENTIN 149 144* 50 55 56
NIFEDIPINE ER 143 143 29 56 39
ISOSORBIDE MONONITRATE ER 143 138* 28 56 15
PRANDIN 141 136* 31 58 193
MONTELUKAST SODIUM 141 141 26 58 78
CIPROFLOXACIN HCL 141 136* 123 58 117
CLOTRIMAZOLE-BETAMETHASONE 140 135* 74 61 148
CELEBREX 140 140 44 61 120
HYDROCHLOROTHIAZIDE 139 139 39 63 14
MELOXICAM 137 132* 71 64 88
ZETIA 135 135 26 65 28
LORAZEPAM 133 128* 53 B 66 113
VALSARTAN-HYDROCHLOROTHIAZIDE 125 120* 18 67 36
AMOX TR-POTASSIUM CLAVULANATE 122 117* 103 68 160
NITROSTAT 120 115* 67 69 37
MECLIZINE HCL 120 120 59 69 86
NAMENDA 120 120 19 69 93
PROAIR HFA 116 111* 41 72 109
CARVEDILOL 116 111* 30 72 8
BETAMETHASONE VALERATE 115 110* 45 74 285
PIOGLITAZONE HCL 115 110* 23 R 74 107
LANTUS SOLOSTAR 115 110* 24 74 141
DILTIAZEM 24HR CD 113 108* 20 77 64
EXFORGE 109 109 21 78 85
FENOFIBRATE* 108 108 19 79 74
ENALAPRIL MALEATE 105 100* 20 80 22
SINGLE USE SWAB 105 105 27 80 253
TRILIPIX 104 104 26 82 170
MULTAQ 99 94* 21 83 89
DOXAZOSIN MESYLATE 97 92* 26 84 63
TRIAMCINOLONE ACETONIDE 96 91* 36 85 227
PROCTOZONE-HC 96 96 28 85 254
PATANOL 94 89* 17 87 301
CLOBETASOL PROPIONATE 94 89* 30 87 174
SERTRALINE HCL 90 90 18 89 57
LIDOCAINE 89 89 38 90 156
ALCOHOL SWABS 88 88 23 91 254
WELCHOL 88 88 23 91 129
LANTUS 83 83 11 93 152
LEVOFLOXACIN 81 76* 66 94 132
NASONEX 76 76 13 95 215
MICARDIS 76 71* 14 95 137
UNIFINE PENTIPS 72 72 17 97 249
LACTULOSE 71 71 16 98 146
SPIRIVA 66 61* 16 99 101
RAMIPRIL 66 61* 15 99 16
TRAMADOL HCL 65 60* 30 101 115
REPAGLINIDE 64 64 24 102 324
SPIRONOLACTONE 64 <11 <11 102 25
TRADJENTA 62 62 17 104 208
VOLTAREN 62 57* 26 104 111
MUPIROCIN* 60 60 27 106 332
ESCITALOPRAM OXALATE 59 <11 <11 107 84
VERAPAMIL ER 58 58 12 108 77
NATEGLINIDE 56 <11 <11 109 246
PROPRANOLOL HCL 55 <11 <11 110 122
RIVASTIGMINE 55 <11 <11 110 349
ERYTHROMYCIN 54 54 12 112 350
DILTIAZEM 24HR ER 51 51 12 113 30
LEVOCETIRIZINE DIHYDROCHLORIDE 51 51 21 113 360
AMOXICILLIN 50 45* 32 115 119
RESTASIS 50 <11 <11 115 366
NORTRIPTYLINE HCL 50 <11 <11 115 261
About This Data

Prescribing data from Medicare’s prescription drug benefit, known as Part D, was compiled and released by the Centers for Medicare and Medicaid Services, the federal agency that oversees the program. ProPublica combined that data with additional information released by CMS. The data for 2013 includes nearly 1.4 billion prescriptions written by 1.3 million doctors, nurses and other providers. This database lists about 410,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths of these prescriptions went to patients 65 and older; the rest were for disabled patients Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to checkup@propublica.org and we will update your information. If you have other questions about this data, send a note to checkup@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Nov. 2, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.